SHERYL ABRAMS: Open Payments
NPI 1609115831 · BRISTOL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 30 payments from 8 companies in 2025. Trend: 2023 $917 · 2024 $559 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 5 | $185 |
| Novo Nordisk Inc | 4 | $167 |
| AstraZeneca Pharmaceuticals LP | 3 | $154 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $133 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| PFIZER INC. | 3 | $59 |
| Baxter Healthcare | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Assure WCD, Wegovy, LifeVest, FASENRA, CAMZYOS, VYNDAQEL, FARXIGA, Hillrom - Cardiac Ambulatory Monitor.
Industry payments across PA — which companies pay providers there.
